Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $254.61. The company's market cap stands at 612.16B, with a P/E ratio of 28.31 and a dividend yield of 2.14%.
On 2026-06-27, Johnson & Johnson(JNJ) stock traded between a low of $246.11 and a high of $255.08. Shares are currently priced at $254.61, which is +3.5% above the low and -0.2% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 16.32M, against a daily average of 10.44M.
During the past year, Johnson & Johnson(JNJ) stock moved between $151.01 at its lowest and $255.08 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $151.01 at its lowest and $255.08 at its peak.
JNJ News
...
Key Points Guggenheim analyst Vamil Divan raised his price target on Johnson & Johnson stock today. Upside is perhaps only 12% over the next year, however. 1...
Johnson & Johnson announced new data across 12 abstracts at the European Academy of Neurology 2026 Congress that offer additional insight into the use of IMAAVY...
Analyst ratings
69%
of 26 ratingsMore JNJ News
Key Points Bristol Myers Squibb maintains a robust biopharmaceutical portfolio focused on high-stakes oncology and immunology treatments. Johnson & Johnson le...
Dividend Safety Check: VIG and the Dividend Appreciation Approach By John Seetoo Published Jun 26, 10:00AM EDT Vanguard Dividend Appreciation ETF (VIG) — larg...
The Portfolio That Quietly Pays Your Property Taxes Forever By Drew Wood Published Jun 26, 9:43AM EDT Quick Read Covering a $6,000 annual property tax bill re...
Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $270 from $266 and keeps a Buy rating on the shares ahead of the company k...
Key Points Johnson & Johnson is on pace to generate roughly $100 billion in revenue in 2026. The company believes it has a unique opportunity to invest in its...
Johnson & Johnson (NYSE:JNJ) is stepping back from the obesity drug market to concentrate its pharmaceutical efforts on cancer treatments. The company is targe...
One Stock to Own For Ultimate Dividend Safety By Vandita Jadeja Published Jun 25, 12:27PM EDT Quick Read JNJ just raised its quarterly dividend 3.1% to $1.34,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.